Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Ann Vasc Surg ; 83: 378.e7-378.e10, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35257918

RESUMO

BACKGROUND: This article describes a chimney technique (ChEVAR) to preserve the patency of the inferior mesenteric artery (IMA) in a patient with abdominal aortic aneurysm (AAA) and bilateral internal iliac artery obstruction. In addition, a review of the literature is performed. CASE REPORT: This article describes a male in his 70s with multiple comorbidities and a 5.6 cm infrarenal aortic aneurysm. CT scan showed bilateral iliac internal artery obstruction with compensatory hypertrophy of lumbar arteries along with a 6 mm inferior mesenteric artery. We planned a staged treatment: embolization of lumbar arteries to prevent type 2 endoleak as a first step, followed two months later by standard EVAR with chimney graft to maintain patency of IMA. The postoperative course was uneventful. The endograft was widely patent on CT scan at his 6-month follow-up visit. CONCLUSIONS: ChEVAR to preserve the patency of IMA is a feasible and valid technique that could be considered in the case of bilateral hypogastric obstruction.


Assuntos
Aneurisma da Aorta Abdominal , Implante de Prótese Vascular , Procedimentos Endovasculares , Aneurisma da Aorta Abdominal/complicações , Aneurisma da Aorta Abdominal/diagnóstico por imagem , Aneurisma da Aorta Abdominal/cirurgia , Implante de Prótese Vascular/métodos , Procedimentos Endovasculares/métodos , Humanos , Artéria Ilíaca/diagnóstico por imagem , Artéria Ilíaca/cirurgia , Masculino , Artéria Mesentérica Inferior/diagnóstico por imagem , Artéria Mesentérica Inferior/cirurgia , Estudos Retrospectivos , Resultado do Tratamento
3.
J Cardiovasc Surg (Torino) ; 62(6): 542-547, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34581552

RESUMO

INTRODUCTION: The main goal of this systematic review was to analyze the outcomes of acute limb ischemia (ALI) in patients suffering from the novel Coronavirus: COVID-19 (SARS-CoV-2). EVIDENCE ACQUISITION: A systematic review on Medline and Embase was conducted up to May 15, 2021. All papers were sorted by abstract and full text by two independent authors. Systematic reviews, commentaries, and studies that did not distinguish status of COVID-19 infection were excluded from review. Patient demographics were recorded along with modality of treatment (endovascular and/or surgical). We analyzed 30-day outcomes, including mortality. Primary outcome was to evaluate clinical characteristic of ALI in patients affected by SARS-CoV-2 in term of location of ischemia, treatment options and 30-day outcomes. EVINDENCE SYNTHESIS: We selected 36 articles with a total of 194 patients. Most patients were male (80%) with a median age of 60 years old. The treatment most used was thromboembolectomy (31% of all surgical interventions). A total of 32 patients (19%) were not submitted to revascularization due to critical status. The rate of technical success was low (68%), and mortality rate was high (35%). CONCLUSIONS: This review confirms that SARS-CoV-2 is associated with a high risk of ALI. Further studies are needed to investigate the association and elucidate potential mechanisms, which may include a hypercoagulable state and hyperactivation of the immune response. Furthermore, management of ALI is not standardized and depends on patient condition and extension of the thrombosed segment. ALI in COVID-19 patients is associated with high risk of failure of revascularization and perioperative mortality.


Assuntos
Anticoagulantes/uso terapêutico , Coagulação Sanguínea/efeitos dos fármacos , COVID-19/terapia , Isquemia/cirurgia , Doença Arterial Periférica/cirurgia , Trombofilia/tratamento farmacológico , Procedimentos Cirúrgicos Vasculares , Doença Aguda , Anticoagulantes/efeitos adversos , COVID-19/sangue , COVID-19/mortalidade , Feminino , Humanos , Isquemia/sangue , Isquemia/mortalidade , Masculino , Pessoa de Meia-Idade , Doença Arterial Periférica/sangue , Doença Arterial Periférica/mortalidade , Complicações Pós-Operatórias/etiologia , Medição de Risco , Fatores de Risco , Trombofilia/sangue , Trombofilia/mortalidade , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares/efeitos adversos , Procedimentos Cirúrgicos Vasculares/mortalidade
4.
Infection ; 47(6): 1059-1063, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31321641

RESUMO

Non-typhoidal Salmonella (NTS) spp. causes about 40% of all infective aortitis and it is characterized by high morbidity and mortality. Human infection occurs by fecal-oral transmission through ingestion of contaminated food, milk, or water (inter-human or zoonotic transmission). Approximately 5% of patients with NTS gastroenteritis develop bacteremia and the incidence of extra-intestinal focal infection in NTS bacteremia is about 40%. The organism can reach an extra-intestinal focus through blood dissemination, direct extension from the surrounding organs and direct bacterial inoculation (e.g. invasive medical procedures). Medical and surgical interventions are both needed to successfully control the infection. Here, we report a case of abdominal sub-renal aortitis caused by Salmonella enterica serovar Enteritidis in an 80-year-old man.


Assuntos
Aorta Abdominal/cirurgia , Aortite/diagnóstico , Infecções por Salmonella/diagnóstico , Salmonella enteritidis/isolamento & purificação , Idoso de 80 Anos ou mais , Aorta Abdominal/patologia , Aortite/microbiologia , Aortite/patologia , Aortite/cirurgia , Humanos , Itália , Masculino , Infecções por Salmonella/microbiologia , Infecções por Salmonella/patologia , Infecções por Salmonella/cirurgia , Resultado do Tratamento
5.
Dig Liver Dis ; 50(1): 84-90, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29017830

RESUMO

BACKGROUND: (18)fluoro-deoxyglucose positron emission tomography/computed tomography (18FDG-PET/CT) might be a useful tool in the management of pancreatic ductal adenocarcinoma (PDAC). AIMS: The aim of this study was to analyze maximum standard uptake value (SUVmax) after 18FDG-PET/CT as predictor of survival outcomes and method to determine treatment strategies. METHODS: A consecutive series of patients who underwent preoperative 18FDG-PET/CT and subsequent resection for PDAC were retrospectively reviewed. Patients who underwent neoadjuvant chemotherapy were excluded. RESULTS: 46 patients were included in the analysis. Median follow-up was 27 months (4-67). Patients who recurred within 12 months showed a significantly higher preoperative median SUVmax (8.1 vs 6.1, p=0.039). Receiver operating characteristics (ROC) curves for disease-free survival (DFS) and disease-specific survival (DSS) identified SUVmax of 6.0 as optimal cut-off. Multivariate analysis showed that SUVmax ≥ 6.0 was an independent predictor of poor DFS (HR 2.288, p=0.024) and DSS (HR 4.875, p<0.001). The combination of SUVmax ≥6.0 with CA19.9 ≥200U/ml was significantly associated with survival outcomes in comparison to patients without concordantly elevated values. CONCLUSION: SUVmax ≥6.0 is an independent predictor of DFS and DSS in resected PDAC. 18FDG-PET/CT might be considered in the preoperative evaluation of patients with pancreatic cancer.


Assuntos
Carcinoma Ductal Pancreático/diagnóstico por imagem , Recidiva Local de Neoplasia/diagnóstico por imagem , Neoplasias Pancreáticas/diagnóstico por imagem , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Ductal Pancreático/mortalidade , Carcinoma Ductal Pancreático/cirurgia , Feminino , Fluordesoxiglucose F18/administração & dosagem , Humanos , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Neoplasias Pancreáticas/mortalidade , Neoplasias Pancreáticas/cirurgia , Cuidados Pré-Operatórios , Curva ROC , Compostos Radiofarmacêuticos/administração & dosagem , Estudos Retrospectivos , Análise de Sobrevida
6.
World J Gastroenterol ; 21(26): 7970-87, 2015 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-26185369

RESUMO

Ampullary neoplasms, although rare, present distinctive clinical and pathological features from other neoplastic lesions of the periampullary region. No specific guidelines about their management are available, and they are often assimilated either to biliary tract or to pancreatic carcinomas. Due to their location, they tend to become symptomatic at an earlier stage compared to pancreatic malignancies. This behaviour results in a higher resectability rate at diagnosis. From a pathological point of view they arise in a zone of transition between two different epithelia, and, according to their origin, may be divided into pancreatobiliary or intestinal type. This classification has a substantial impact on prognosis. In most cases, pancreaticoduodenectomy represents the treatment of choice when there is an overt or highly suspicious malignant behaviour. The rate of potentially curative resection is as high as 90% and in high-volume centres an acceptable rate of complications is reported. In selected situations less invasive approaches, such as ampullectomy, have been advocated, although there are some concerns mainly because of a higher recurrence rate associated with limited resections for invasive carcinomas. Importantly, these methods have the drawback of not including an appropriate lymphadenectomy, while nodal involvement has been shown to be frequently present also in apparently low-risk carcinomas. Endoscopic ampullectomy is now the procedure of choice in case of low up to high-grade dysplasia providing a proper assessment of the T status by endoscopic ultrasound. In the present paper the evidence currently available is reviewed, with the aim of offering an updated framework for diagnosis and management of this specific type of disease.


Assuntos
Ampola Hepatopancreática/cirurgia , Doenças do Ducto Colédoco/cirurgia , Endoscopia do Sistema Digestório , Pancreaticoduodenectomia , Algoritmos , Ampola Hepatopancreática/patologia , Doenças do Ducto Colédoco/epidemiologia , Doenças do Ducto Colédoco/mortalidade , Doenças do Ducto Colédoco/patologia , Procedimentos Clínicos , Endoscopia do Sistema Digestório/efeitos adversos , Endoscopia do Sistema Digestório/mortalidade , Humanos , Excisão de Linfonodo , Estadiamento de Neoplasias , Pancreaticoduodenectomia/efeitos adversos , Pancreaticoduodenectomia/mortalidade , Valor Preditivo dos Testes , Fatores de Risco , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...